Mrs Marianne Lachaux
INSERM U1096, Rouen (France)
Acute imeglimin treatment improves metabolic syndrome-related cardiac and coronary endothelial dysfunction in the zucker fa/fa rat
Event: ESC Congress 2018
Topic: Antidiabetic Pharmacotherapy
Session: Best Posters in cardiovascular remodelling
Short- and long-term imeglimin treatment reduces metabolic syndrome-related diabetic cardiomyopathy
Event: ESC Congress 2017
Topic: Diastolic dysfunction
Session: Chronic heart failure (CHF)
Improved metabolic syndrome-related right and left ventricular dysfunction by the dual ETA-ETB receptor antagonist macitentan.
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Pulmonary hypertension
Session: Basic science - Animal experimentation
